What does Eikon Therapeutics, Inc. do?

Eikon Therapeutics, Inc. is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in DE. It is registered with the SEC under CIK 0001861123 and trades on NASDAQ under the ticker EIKN.

How many SEC filings has Eikon Therapeutics, Inc. made?

Eikon Therapeutics, Inc. has filed 46 documents with the SEC since 2021. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Eikon Therapeutics, Inc.

EIKN NASDAQ CIK: 0001861123 Biological Products, (No Diagnostic Substances) Inc. in DE

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 46 filings →

Form	Description	Date
4	4	Mar 4, 2026
4	4	Mar 4, 2026
4	4	Mar 4, 2026
4	4	Mar 4, 2026
4	4	Mar 4, 2026
4	4	Mar 4, 2026
4	4	Mar 4, 2026
SCHEDULE 13G	—	Feb 18, 2026
SCHEDULE 13D	—	Feb 12, 2026
SCHEDULE 13G	—	Feb 11, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Eikon Therapeutics, Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001861123
Ticker: EIKN
Exchange: NASDAQ
Incorporated: DE
First Filing: 2021
Total Filings: 46

Biological Products, (No Diagnostic Substances) rankings →